Deal Law Wire

FEBRUARY 9, 2021

These developments allow retail investors to create substantial trends and market fluctuations in the prices of securities, as well as being a relatively-newfound and rather robust source of capital. Private Companies. The author would like to thank Arron Chahal, Articling Student, for his significant contribution to this blog post.

Retail 40

Retail Investors M&A Negotiation 40

Razorpay

JULY 27, 2023

Investment Banking Services Initial Public Offering (IPO) When a privately-owned business wants to become a publicly traded company, it goes through an IPO , or Initial Public Offering. Investment Banks help businesses with valuations, deal negotiations, and more. How do they do this?

Investment Banking 52

Investment Banking Bank Banking Investment 52

Focus Investment Banking

FEBRUARY 25, 2024

I still recall the metric that was drilled into me back then: hit $50 million in revenue and a few back-to-back years of profitability and you, too, can go public. The benefits of going public are significant. It turns out that there are fewer public companies of all types across all industries. stock market.

Private Equity 52

Private Equity IPO Equities Public Trading 52

RKJ Partners

AUGUST 6, 2017

Most entrepreneurs are very familiar with senior debt offered by traditional banks. Senior debt is first in seniority and is often secured by collateral in the form of a lien. Senior debt is financing that has been loaned to a company for a pre-negotiated period of time with interest paid on the principal.

Debt 40

Debt Capital Raising Capital Equities 40

Cooley M&A

MARCH 22, 2023

With the US initial public offering markets continuing to remain largely closed, and special purpose acquisition company combinations being costly and complex, there’s a new kid in town for foreign companies looking to go public in the US: reverse mergers. securities laws for the share issuances. company.

Mergers 52

Mergers IT Mergers and Acquisitions IPO 52

Cooley M&A

JANUARY 25, 2023

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

SEPTEMBER 16, 2022

The rise of founder-led, venture capital-backed companies in recent years has coincided with a surge of companies implementing dual-class share structures in connection with their initial public offerings. Afford the acquirer certain notice and match rights if a topping bid does emerge.

M&A 59

M&A IPO Mergers and Acquisitions Shares 59